Literature DB >> 1684556

[Beta blockers and corneal sensitivity].

H Höh1, W Nastainczyk.   

Abstract

We performed several placebo-controlled, randomized, prospective, parallel, double-masked studies in ophthalmologically healthy people to determine the local anesthetic effect and the topical subjective tolerability of beta blockers with similar potency of action that are available in the Federal Republic of Germany. There are marked differences in the local anesthetic effects of the different beta blockers. Depending on the type of beta blockers the local anesthetic effect ranges from practically none up to anesthesia allowing contact glass examinations and removal of foreign bodies after application of only one drop. The subjective tolerability becomes worse with increasing strength of local anesthetic effect of the beta-blocker. There is a statistically significant correlation between the subjective tolerability and local anesthetic effect and the octanol-water distribution coefficient. Because of the local anesthetic effect, we recommend repeated checks of corneal sensitivity during beta blocker therapy. This should be done more frequently in people with sensitive eyes, "responders," contact lens wearers, and people with reduced corneal sensitivity for other reasons, especially during therapy with beta-blockers with marked local anesthetic effects. In addition to systemic side effects, cardioselectivity, influence on tear film, intrinsic sympathomimetic activity and topical tolerance, etc., the local anesthetic effect of beta blockers is a further important aspect in the "differential indications" of beta-blockers.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1684556

Source DB:  PubMed          Journal:  Fortschr Ophthalmol        ISSN: 0723-8045


  3 in total

1.  Effects of a long-acting ophthalmic formulation of carteolol containing alginic acid on the corneal epithelial barrier function and water retentive effect.

Authors:  Naoto Tokuda; Jun Inoue; Izumi Yamazaki; Satoki Ueno; Sigeki Fujisawa
Journal:  J Ocul Pharmacol Ther       Date:  2012-01-04       Impact factor: 2.671

Review 2.  Ocular carteolol: a review of its use in the management of glaucoma and ocular hypertension.

Authors:  Sheridan Henness; Tracy Swainston Harrison; Gillian M Keating
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

3.  Comparison of the 24-h efficacy and safety of fixed combination carteolol/latanoprost and timolol/latanoprost in patients with primary open-angle glaucoma and ocular hypertension: a prospective crossover study.

Authors:  Yuta Saito; Junichiro Kizaki; Yoshihiro Wada; Yoshiyuki Shibasaki; Nobuharu Kishimoto; Makoto Aihara
Journal:  Jpn J Ophthalmol       Date:  2021-07-19       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.